1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer
@Fat_Wolf @Meg_Alice_Holms thanks for the feedback and we are hoping to collect some case studies like this as they… https://t.co/7QRAbSVuC8

Corona Virus: We are still here but physical orders are delayed as our staff are remote working. When we return to the office we will clear the backlog ASAP.  More Info on Coronavirus Our helpline continues to be available between 10 and 4 weekdays on 0300 999 3333

Contact Form Issues - We are having some issues with our contact forms. If they do not work please email head.office@fmauk.org.


2 weeks till new fibro drug?


Following up on your previous article on sodium oxybate in December last year, the time is fast approaching where we will find out if the New drug application by Jazz pharmaceuticals will be approved by the FDA. 

In June 2009 when we spoke about Sodium Oxybate the following was said about positive trials:

Jazz Pharmaceuticals and UCB announced on 24th June 2009 that there have been positive preliminary  results from the second of two Phase III clinical trials of Sodium Oxybate (JZP-6) for treatment in Fibromyalgia.

Of course when we find out more about this promising addition to the fibro meds on offer we will let you know. You can read Adrienne Dellewo's take on this here.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Cookie Use Page.

I accept cookies from this site.